| 發表者 | 討論主題：wPwFPWFfKFOLjjdTl | ||
| Alexander | 8/6/2014 5:31:43 PM [瞻p穢j]•[繡礙簞T繚~]•[瞼x穠F聶瞻瞼竄] | 
|
|
| Would you like to leave a message? http://www.mikrokoulutus.fi/valmennus/ praziquantel biltricide Thousand Oaks, California-based Amgen, whose preliminary $120 per-share offer for Onyx was rejected by the company's board last month, is still keen to buy the cancer drugmaker and waiting to see if a higher competing offer will materialize, the people said on Wednesday. | |||